financetom
Business
financetom
/
Business
/
Investors switch from private equity to hedge funds, says BNP Paribas report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investors switch from private equity to hedge funds, says BNP Paribas report
Feb 13, 2025 3:44 AM

LONDON, Feb 13 (Reuters) - Investors are choosing hedge

funds rather than re-upping their private equity investments

after closed deals, as deal making in recent years has dried up,

said BNP Paribas.

WHY IT'S IMPORTANT

Large institutions have become wary of a souring in public

markets as they seek to put their money into the hands of

people that trade in a way that is either contrary to broader

markets, or less exposed to their swings.

KEY QUOTES

"Markets have gone from this pre-inflation world where

everything was rising. Rates were low, stocks soared and

investors dropped active management for passive," said Marlin

Naidoo, global head of capital introduction at BNP Paribas in

London.

This was a sign that investors were shifting back towards

active management, Naidoo said.

CONTEXT

In 2022 and 2023, investors yanked $52 billion from top

performing hedge funds. While it is not unusual to ditch low

performing hedge funds, this exodus was driven by pension funds

and universities sacrificing their strongest investments to hold

on to private equity and venture capital portfolios which at

that time were beginning to cost more than they yield.

The kind of deal making private equity relies on to see bets

pay off, has not returned. Global private equity and venture

capital transactions totaled $35.28 billion in January, down $70

million from January 2024, according to a S&P Global Market

Intelligence report last week.

BY THE NUMBERS

Investors surveyed by BNP Paribas said they added a net

$22.2 billion of assets to their portfolios.

Almost a fifth flowed that into hedge funds last year

was from private equity investors. Investors also ditched long

only equity and long only bond investments for hedge funds.

WHAT'S NEXT

Roughly two thirds of the 290 investors surveyed said they

would increase their hedge fund allocations.

GRAPHIC

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AMC Entertainment Stock Is Rising Monday: What's Going On?
AMC Entertainment Stock Is Rising Monday: What's Going On?
Jul 29, 2024
AMC Entertainment Holdings Inc ( AMC ) shares are on watch higher. The company announced it posted its highest weekend attendance and admissions revenue of 2024. What Happened: AMC announced that it set new 2024 records for weekend attendance and admissions revenue at its U.S. AMC theater locations this past Thursday through Sunday. AMC also set new 2024 records at its...
Enlight Renewable Energy Finalizes $827 Million Financing for Atrisco Solar and Storage Project
Enlight Renewable Energy Finalizes $827 Million Financing for Atrisco Solar and Storage Project
Jul 29, 2024
11:25 AM EDT, 07/29/2024 (MT Newswires) -- Enlight Renewable Energy ( ENLT ) announced Monday the financial close for the energy storage portion of its Atrisco Solar and Energy Storage project near Albuquerque, New Mexico. The $827 million project, combining 364 MW of solar capacity with 1.2 GWh of battery storage, will be financed by term debt of $290 million...
Enstar to be Acquired by Sixth Street-Led Group in $5.1 Billion Deal
Enstar to be Acquired by Sixth Street-Led Group in $5.1 Billion Deal
Jul 29, 2024
11:24 AM EDT, 07/29/2024 (MT Newswires) -- Enstar Group ( ESGR ) agreed to be taken private by a Sixth Street-led consortium in a $5.1 billion deal. Liberty Strategic Capital, JC Flowers and other institutional investors will also be participating in the transaction, according to a statement released Monday. The per-cash consideration of $338 represents a premium of about 8.5%...
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
Jul 29, 2024
vTv Therapeutics Inc. ( VTVT ) stock is trading lower on Monday. The FDA has placed a clinical hold on the cadisegliatin clinical program, which includes the ongoing CATT1 Phase 3 trial in type 1 diabetes.  Cadisegliatin is an oral, liver-selective, glucokinase activator. The company says the drug candidate has been well-tolerated in over 500 subjects to date with up to six...
Copyright 2023-2026 - www.financetom.com All Rights Reserved